Family Wealth Partners’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Sell
6,383
-1,340
-17% -$76.9K 0.11% 71
2026
Q1
$468K Buy
7,723
+2,203
+40% +$128K 0.16% 60
2025
Q4
$298K Buy
+5,520
New +$266K 0.11% 68

Other funds holding BMY

Family Wealth Partners's BMY Position: Q2 2026 in Review

Family Wealth Partners reduced its Bristol-Myers Squibb (BMY) stake by 17% in Q2 2026, selling an estimated $76.9K and leaving 6,383 shares worth $368K. The position accounts for 0.11% of the portfolio, ranked #71.

Family Wealth Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $468K in Q1 2026. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Family Wealth Partners held 6,383 shares of Bristol-Myers Squibb worth $368K as of Q2 2026.
  • Family Wealth Partners sold 1,340 Bristol-Myers Squibb shares in Q2 2026, an estimated $76.9K.
  • Bristol-Myers Squibb made up 0.11% of Family Wealth Partners's portfolio in Q2 2026, its #71 holding.
  • Family Wealth Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
  • Family Wealth Partners's Bristol-Myers Squibb position peaked at $468K in Q1 2026.
  • 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Family Wealth Partners's 13F filing for Q2 2026, filed 10 Jul 2026.